Page 5 - Celltrion Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Celltrion group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Celltrion Group Today - Breaking & Trending Today

Chairman's daughters from extramarital affair seen as risk to Celltrion's governance

Celltrion is facing uncertainties over Chairman Seo Jung-jin s potential handover of his management rights to his two sons, Celltrion Board Chairman Seo Jin-seok and Celltrion Healthcare Board Chairman Seo Joon-serk, as it was found recently that his two daughters from an extramarital affair had been recognized last year as his biological children, according to industry officials, Thursday. ....

Kyonggi Do , South Korea , Seo Joon Serk , Seo Jin Seok , Seo Jung Jin , Seorin Holdings , Celltrion Holdings , Celltrion Group , Fair Trade Commission , Celltrion Chairman Seo Jung Jin , Chairman Seo Jung Jin , Celltrion Board Chairman Seo Jin Seok , Celltrion Healthcare Board Chairman Seo Joon Serk , South Korea , He Korea Times , Orea Times , Orean News In English ,

Celltrion to merge three of its business units and pursue M&A this year

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions. ....

Seo Jung Jin , Celltrion Inc , Celltrion Healthcare Co , Celltrion Group , Baxter International Inc , Celltrion Pharm Inc , Baxter International , Pulse News , Celltrion Healthcare , Joongang Daily , Real Time Economy News , Orex News , Igital Currency News , Conomy Research , Conomy Commentaries ,

Celltrion chairman vows to develop new drugs, initiate M&As

Seo Jung-jin, founder and chairman of Celltrion, vowed to transform the biosimilar maker into a leading new drug maker and launch a series of merger and acquisition (M&A) activities to diversify its business portfolio during an online press conference, Wednesday. ....

Seo Jung Jin , Baek Byung Yeul , Joe Biden , Celltrion Pharm , Seo Jin Seok , Celltrion Group , Mirae Asset Group , Iksuda Therapeutics , Mirae Asset , Celltrion Healthcare , South Korea , He Korea Times , Orea Times , Orean News In English ,

Celltrion chairman vows to develop new drugs, initiate M&As

Seo Jung-jin, founder and chairman of Celltrion, vowed to transform the biosimilar maker into a leading new drug maker and launch a series of merger and acquisition (M&A) activities to diversify its business portfolio during an online press conference, Wednesday. ....

Seo Jung Jin , Joe Biden , Celltrion Pharm , Seo Jin Seok , Baek Byung Yeul , Mirae Asset Group , Celltrion Group , Iksuda Therapeutics , Mirae Asset , Celltrion Healthcare , South Korea , He Korea Times , Orea Times , Orean News In English ,

BioBlast w/e 03 Mar 23:

Biospectrum India reported that Enzene Biosciences has launched its adalimumab (biosimilar to AbbVie’s Humira®) in India for the treatment of… ....

South Korea , West Virginia , United States , South Korean , Amgen Stelara , Enzene Biosciences , Samsung Biologics , Johnson Stelara , Genentech Herceptin , Samsung Bioepis , Robert Wessman , Abbvie Humira , Celltrion Samsung Bioepis , Seo Jung Jin , Us District Court Of Delaware , Us District Court , District Court , Us Janssen Biotech Inc , National Medical Products Administration , Cn Eisai Co , Celltrion Group , Janssen Biotech Inca Johnson , Immune Thrombocytopenic Purpura , Priority Review , Janssen Biotech , Court Judge Noreika ,